Jurjen J Luykx
Affiliation: University Medical Center Utrecht
Country: The Netherlands
- Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findingsJ J Luykx
Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
Neurosci Biobehav Rev 36:198-205. 2012..These results fit the central role of the ACC in depressive symptomatology and suggest that in MDD changes in glutamatergic neurotransmission are state-dependent...
- Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraineJ Luykx
Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California at Los Angeles, Los Angeles, California, USA
Clin Pharmacol Ther 85:283-8. 2009..03-2.98) for 50 mg but no different for the other doses. We conclude that when treated with the same doses of topiramate, migraineurs show different ADRs than patients with epilepsy and are more likely to drop out because of ADRs...
- The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studiesJ J Luykx
Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, B01 206, P O Box 85500, 3508 GA Utrecht, The Netherlands
Eur Neuropsychopharmacol 20:357-68. 2010..Future studies investigating the effects of GSK3beta manipulation in BD seem warranted...
- Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disordersJurjen J Luykx
University Medical Center Utrecht, Department of Psychiatry, p a Jurjen Luykx, PO Box 85500, 3508 GA Utrecht HP B01 206, The Netherlands
Expert Opin Drug Saf 9:623-31. 2010..Studying ADR profiles across disorders is clinically relevant because treatment decision-making in neuropsychiatry is highly guided by ADR profiles...